Lexicon Pharmaceuticals, Inc. (LXRX)
1.635
-0.02
(-0.91%)
USD |
NASDAQ |
Oct 13, 09:45
Lexicon Pharmaceuticals Net Income (TTM) : -61.12M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -61.12M |
| March 31, 2026 | -26.09M |
| December 31, 2025 | -50.34M |
| September 30, 2025 | -68.58M |
| June 30, 2025 | -120.62M |
| March 31, 2025 | -177.30M |
| December 31, 2024 | -200.40M |
| September 30, 2024 | -214.88M |
| June 30, 2024 | -200.60M |
| March 31, 2024 | -192.07M |
| December 31, 2023 | -175.61M |
| September 30, 2023 | -157.86M |
| June 30, 2023 | -130.72M |
| March 31, 2023 | -110.40M |
| December 31, 2022 | -101.94M |
| September 30, 2022 | -97.06M |
| June 30, 2022 | -96.80M |
| March 31, 2022 | -90.28M |
| December 31, 2021 | -87.76M |
| September 30, 2021 | -67.64M |
| June 30, 2021 | 38.08M |
| March 31, 2021 | -12.92M |
| December 31, 2020 | -58.57M |
| September 30, 2020 | -104.22M |
| June 30, 2020 | 39.27M |
| Date | Value |
|---|---|
| March 31, 2020 | 85.32M |
| December 31, 2019 | 130.13M |
| September 30, 2019 | 164.49M |
| June 30, 2019 | -88.99M |
| March 31, 2019 | -100.52M |
| December 31, 2018 | -120.55M |
| September 30, 2018 | -132.14M |
| June 30, 2018 | -135.47M |
| March 31, 2018 | -135.98M |
| December 31, 2017 | -129.05M |
| September 30, 2017 | -133.09M |
| June 30, 2017 | -138.38M |
| March 31, 2017 | -141.44M |
| December 31, 2016 | -141.43M |
| September 30, 2016 | -22.26M |
| June 30, 2016 | -21.53M |
| March 31, 2016 | -11.49M |
| December 31, 2015 | -4.682M |
| September 30, 2015 | -94.36M |
| June 30, 2015 | -99.58M |
| March 31, 2015 | -97.54M |
| December 31, 2014 | -100.29M |
| September 30, 2014 | -114.78M |
| June 30, 2014 | -105.94M |
| March 31, 2014 | -108.99M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Bristol Myers Squibb Co. | 9.275B |
| ANI Pharmaceuticals, Inc. | 99.95M |
| Corcept Therapeutics, Inc. | 54.20M |
| Veru, Inc. | -14.11M |
| Johnson & Johnson | 21.04B |